The COVID-19 pandemic has not only stimulated interest in new modalities research but also sparked a resurgence in formulation approaches among biopharmaceutical companies, leading to the development of a new wave of drug substances and therapeutics. Over the past year, intranasal delivery methods have shown clinical efficacy for novel therapeutics
17-18 May 2023